Liminatus Pharma, Inc. Soared
Thu, Feb 05, 2026 at 07:41 PM
Liminatus Pharma, Inc. (LIMN:NASDAQ) shot up at $2.05, representing a gain of 43.4%. On Thu, Feb 05, 2026, LIMN:NASDAQ hit a New 2-Week High of $2.05. From Fri, Jan 23, 2026, the stock recorded 44.44% Up Days and 40.00% Green Days
About Liminatus Pharma, Inc. (LIMN:NASDAQ)
Liminatus Pharma, Inc. is pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 1333.33%
- F45 Training Holdings Inc. (FXLV:NYSE), 627.27%
- Lafayette Digital Acquisition Corp. I (ZKPW:NASDAQ), 260%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 43.36%
- UTime Limited (WTO:NASDAQ), 38.38%
- C3is Inc. (CISS:NASDAQ), 28.95%
- TruGolf Holdings, Inc. (TRUG:NASDAQ), 27.95%
- CytoMed Therapeutics Limited (GDTC:NASDAQ), 27.07%
- Estrella Immunopharma, Inc. (ESLA:NASDAQ), 25.71%
- Phibro Animal Health Corporation (PAHC:NASDAQ), 21.95%